{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T14:03:41Z","timestamp":1784729021062,"version":"3.55.0"},"reference-count":17,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,3,20]],"date-time":"2024-03-20T00:00:00Z","timestamp":1710892800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Hepatoblastoma is the most common malignant primary liver tumor in the pediatric population, accounting for 67% of cases in the United States. Surgical resection is the only curative treatment option; however, it can be performed in only 10% of patients with primary tumors. The two most common limitations for resection are the need for extensive resections and tumors in central locations. The therapeutic hypertrophy of healthy tissue achieved with ALPPS (Associating Liver Partition and Portal vein ligation for Staged Hepatectomy) enables larger resections and has been successfully employed in the pediatric population in recent years.<\/jats:p><\/jats:sec><jats:sec><jats:title>Objective<\/jats:title><jats:p>To present three cases of patients with centrally located PRETEXT II or III hepatoblastomas who underwent ALPPS procedure as a viable therapeutic alternative to liver transplantation.<\/jats:p><\/jats:sec><jats:sec><jats:title>Discussion and results<\/jats:title><jats:p>Central PRETEXT III hepatoblastomas are typically indications for liver transplantation. Transplantation offers high five-year survival rates (73%). However, the associated morbidity, healthcare system costs, and limited availability make it necessary to explore alternative options. Series have reported the successful application of the ALPPS procedure in PRETEXT II and PRETEXT III hepatoblastomas in other locations. Therapeutically induced hypertrophy, characterized by an increase in the volume of healthy tissue in unaffected lobes or segments, enabled the resection of previously deemed unresectable lesions. The patients experienced uncomplicated postoperative courses and expected reduction in tumor markers. Chemotherapy selection followed the guidelines outlined in Block C of the SIOPEL IV protocol.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>ALPPS hepatectomy is a viable therapeutic option for patients with centrally located PRETEXT III or II hepatoblastomas.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fped.2024.1350697","type":"journal-article","created":{"date-parts":[[2024,3,20]],"date-time":"2024-03-20T05:20:46Z","timestamp":1710912046000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Case Report: ALPPS hepatectomy, an alternative to liver transplantation in central PRETEXT III hepatoblastomas: a case series"],"prefix":"10.3389","volume":"12","author":[{"given":"Isabel Cristina","family":"Garcia Moreno","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Alzate-Ricaurte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edgar Dario","family":"Alzate Gallego","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Hincapie-Ayala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oscar Javier","family":"Serrano Ardila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge Ivan","family":"Villegas Otalora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,3,20]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1053\/jhep.2003.50375","article-title":"Epidemiology of primary hepatic malignancies in U.S. children","volume":"38","author":"Darbari","year":"2003","journal-title":"Hepatology"},{"key":"B2","doi-asserted-by":"publisher","first-page":"3909","DOI":"10.1002\/cam4.5300","article-title":"Recent advances in surgical strategies and liver transplantation for hepatoblastoma","volume":"12","author":"Honda","year":"2023","journal-title":"Cancer Med"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1016\/j.jpedsurg.2014.10.019","article-title":"Associating liver partition with portal vein ligation and staged hepatectomy (ALPPS) for the treatment of liver tumors in children","volume":"50","author":"Wiederkehr","year":"2015","journal-title":"J Pediatr Surg"},{"key":"B4","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1002\/pbc.10376","article-title":"Liver transplantation for hepatoblastoma: results from the international society of pediatric oncology (SIOP) study SIOPEL-1 and review of the world experience","volume":"42","author":"Otte","year":"2004","journal-title":"Pediatr Blood Cancer"},{"key":"B5","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1097\/SLA.0b013e31824856f5","article-title":"Right portal vein ligation combined with in situ splitting induces rapid left lateral liver lobe hypertrophy enabling 2-staged extended right hepatic resection in small-for-size settings","volume":"255","author":"Schnitzbauer","year":"2012","journal-title":"Ann Surg"},{"key":"B6","doi-asserted-by":"publisher","first-page":"352","DOI":"10.14701\/ahbps.2020.24.3.352","article-title":"A minimally invasive first stage of ALPPS for hepatoblastoma in a child","volume":"24","author":"Akhaladze","year":"2020","journal-title":"Ann Hepatobiliary Pancreat Surg"},{"key":"B7","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s12957-021-02156-y","article-title":"Two-stage laparoscopic resection of giant hepatoblastoma in infants combined with liver partial partition and artery ligation","volume":"19","author":"Wu","year":"2021","journal-title":"World J Surg Oncol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.ejso.2020.09.001","article-title":"Post hepatectomy liver failure (PHLF)\u2014recent advances in prevention and clinical management","volume":"47","author":"S\u00f8reide","year":"2021","journal-title":"Eur J Surg Oncol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.jpedsurg.2017.10.035","article-title":"Liver transplantation for primary hepatic malignancies of childhood: the UNOS experience","volume":"53","author":"Hamilton","year":"2017","journal-title":"J Pediatr Surg"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.1016\/j.transproceed.2019.04.026","article-title":"Financial burden of liver transplant vs resection for hepatocellular carcinoma","volume":"51","author":"Skill","year":"2019","journal-title":"Transplant Proc"},{"key":"B11","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1002\/pbc.29425","article-title":"Waitlist mortality and post-liver transplant outcomes of pediatric patients with hepatocellular carcinoma and hepatoblastoma in the United States","volume":"69","author":"Wu","year":"2022","journal-title":"Pediatr Blood Cancer"},{"key":"B12","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1002\/lt.25427","article-title":"Liver transplant in Colombia","volume":"25","author":"Salinas Nova","year":"2019","journal-title":"Liver Transpl"},{"key":"B13","author":"Mej\u00eda","year":""},{"key":"B14","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3389\/fped.2022.915642","article-title":"Evidence on indications and techniques to increase the future liver remnant in children undergoing extended hepatectomy: a systematic review and meta-analysis of individual patient data","volume":"10","author":"Fuchs","year":"2022","journal-title":"Front Pediatr"},{"key":"B15","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.soc.2014.09.008","article-title":"Complications following hepatectomy","volume":"24","author":"Russell","year":"2015","journal-title":"Surg Oncol Clin N Am"},{"key":"B16","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1159\/000335713","article-title":"How much remnant is enough in liver resection?","volume":"29","author":"Guglielmi","year":"2012","journal-title":"Dig Surg"},{"key":"B17","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s00383-022-05356-z","article-title":"Surgical management in hepatoblastoma: points to take","volume":"39","author":"Murawski","year":"2023","journal-title":"Pediatr Surg Int"}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2024.1350697\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,20]],"date-time":"2024-03-20T05:20:49Z","timestamp":1710912049000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2024.1350697\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,20]]},"references-count":17,"alternative-id":["10.3389\/fped.2024.1350697"],"URL":"https:\/\/doi.org\/10.3389\/fped.2024.1350697","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,20]]},"article-number":"1350697"}}